Crataeva 1:2 500ml

Regular price $203.95 AUD

Key Benefits

  • Helps manage kidney and bladder stones naturally, supporting urinary health.
  • Promotes healthy bladder function, helping to maintain optimal bladder tone.
View full range — Mediherb Liquid

💗 Australian-owned • Independent wellness

Practitioner-grade support. Always read the label and follow the directions for use.

Join Wellness Circle

Member pricing on orders $200+ and exclusive perks

Shipping & Dispatch $19.95 flat rate · Free over $200

Australia Post — fully trackable.


  • Free shipping: $200+
  • Flat rate: $19.95 Australia-wide

Dispatch: usually within 1–3 business days

Herbal Support for Kidney and Bladder Health

MediHerb’s Crataeva 1:2, derived from the bark of Crataeva magna, is a traditional Ayurvedic herbal remedy known for supporting kidney and bladder health. It aids in the natural management of bladder tone, urinary tract inflammation, and kidney and bladder stones.


  • Kidney and Bladder Stone Support: Helps manage kidney and bladder stones naturally, supporting urinary health.
  • Bladder Tone Support: Promotes healthy bladder function, helping to maintain optimal bladder tone.
  • Urinary Tract Inflammation Relief: Eases inflammation of the urinary tract, providing relief from discomfort.
  • Natural support for kidney and bladder stone management.
  • Herbal support for maintaining healthy bladder tone.
  • Relief from urinary tract inflammation and discomfort.
  • Botanical Name: Crataeva magna
  • Plant Part Used: Bark
  • Ethanol Content: 23%, ensuring effective extraction of active constituents.
  • Adults: Take 40-100 mL per week, adjusted based on individual needs and under the guidance of a healthcare provider.


No added Gluten or Dairy. This product is vegan-friendly, making it suitable for various dietary preferences.

  • Caution is advised during pregnancy and lactation.
  • If pain or irritation associated with cystitis persists for more than 48 hours, consult your doctor.
  • blood in the urine warrants immediate medical attention.
  • Discontinue use 7 days prior to general anesthesia.